Unveiling the therapeutic potential of thymol from Nigella sativa L. seed: selective anticancer action against human breast cancer cells (MCF-7) through down-regulation of Cyclin D1 and proliferative cell nuclear antigen (PCNA) expressions.
Thymol derived from Nigella sativa can potentially inhibit the growth of breast cancer cells by suppressing the expression of key genes involved in cell proliferation.
- Vahitha V et al (2024).
- Mol Biol Rep.
- PubMed:
- 38170326